Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one, composition containing them, and method of using them to treat cardiac failure

摘要

Orally active prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-[4-(2-methyl-1_H-imidazol-1-yl)benzoyl]-2_H-imid azol-2-one are disclosed. Pharmaceutical formulations containing such compounds are also provided.